Prescription drug · ANDA
Cleocin Pediatric (clindamycin palmitate hydrochloride) NDC 0009-0760
Clindamycin palmitate hydrochloride 75 mg/5mL · Granule, For solution · Oral · Pharmacia & Upjohn Company LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0009-0760-12 | 00009076012 | 1 BOTTLE in 1 CARTON (0009-0760-12) / 100 mL in 1 BOTTLEMarketed from Nov 11, 2025 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Cleocin Pediatric
- Generic name (nonproprietary)
- clindamycin palmitate hydrochloride
- Active ingredients
- Clindamycin palmitate hydrochloride — 75 mg/5mL
- Dosage form
- Granule, For solution
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 062644
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
- Identifiers
- Product ID 0009-0760_4e119e2e-c280-4945-a5f3-1fa9ab81b422SPL ID 4e119e2e-c280-4945-a5f3-1fa9ab81b422SPL set ID 1ef87b6c-9d32-44ac-8c55-8bf01424cc45RxCUI 562266, 748743UNII VN9A8JM7M7
- Pharmacologic class
- Lincosamide Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400009076012followed by a unit qualifier and the quantityPackage 00009-0760-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE CLEOCIN PEDIATRIC (clindamycin palmitate HCl) is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of colitis, as described in the BOXED WARNING , before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin). Anaerobes: Seriou…
Excerpt only. Read the full label for complete information.